Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
English (EN)
Adolescents
Adults
Clear all
Type of publications
NITAG documentation
(10)
Topics
Regions
Africa
(1)
Americas
(8)
Western Pacific
(1)
Countries
Australia
(1)
Canada
(3)
Uganda
(1)
United States of America
(5)
Diseases
COVID-19
(4)
Hepatitis A
(1)
Hepatitis B
(1)
Herpes zoster
(1)
Human papillomavirus (HPV)
(2)
Influenza
(2)
Japanese encephalitis
(2)
Meningococcal disease
(1)
Mumps
(1)
Pertussis
(1)
Pneumococcal disease
(5)
Rabies
(1)
Publication date
2023
(1)
2022
(5)
2021
(2)
2018
(1)
2017
(1)
Target population
Adolescents
(5)
Adults
(7)
All age groups
(1)
Children
(14)
Healthcare workers
(4)
Newborn
(4)
Older adults
(9)
Pregnant women
(6)
Risk group
(4)
Available to download in languages
English (EN)
(10)
French (FR)
(2)
10 results found
2023
∙
NACI
Public health level recommendations on the use of pneumococcal vaccines in adults, including the use of 15-valent and 20-valent conjugate vaccines
2022
∙
NACI
Updated recommendations on the use of COVID-19 vaccine booster doses in children 5 to 11 years of age and concurrent vaccine administration
2022
∙
ACIP
Universal Hepatitis B Vaccination in Adults Aged 19–59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
2022
∙
ACIP
Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
2022
∙
ACIP
Use of 15-Valent Pneumococcal Conjugate Vaccine Among U.S. Children: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
2022
∙
UNITAG
Advisory on Ministry of Health proposal to vaccinate persons 5-17 years of age against COVID-19 in Uganda
2021
∙
ATAGI
ATAGI statement on AstraZeneca vaccine in response to new vaccine safety concerns - 8 April, 2021
2021
∙
NACI
NACI rapid response: Recommended use of AstraZeneca COVID-19 vaccine in younger adults
2018
∙
ACIP
October 2018 - meeting minutes
2017
∙
ACIP
October 2017 - meeting minutes
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register